← Open Payments lookup

BRYON EVANS: Open Payments

NPI 1942280011 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$123,446 in 345 payments from 27 companies in 2025. Trend: 2023 $22,064 · 2024 $46,437 · 2025 $123,446

Speaker / faculty: $60,331Honoraria: $40,700Travel & lodging: $10,324Food & beverage: $6,585Consulting: $5,500Education: $5
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.66$46,395
Otsuka America Pharmaceutical, Inc.62$43,433
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)52$30,511
Neurocrine BioSciences, Inc.22$639
Alkermes, Inc.17$388
Teva Pharmaceuticals USA, Inc.26$274
Axsome Therapeutics, Inc.16$257
Noven Therapeutics, LLC12$217
Janssen Pharmaceuticals, Inc12$212
Vanda Pharmaceuticals Inc.9$165

Products named: Qelbree, REXULTI, CAPLYTA, INGREZZA, ARISTADA, Auvelity, Xelstrym, FANAPT.

Industry payments across GA — which companies pay providers there.